Back to top
more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$87.59 USD

87.59
5,119,705

-1.18 (-1.33%)

Updated Nov 14, 2024 04:00 PM ET

After-Market: $87.59 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Products

Zacks News

What's in Store for Boston Scientific's (BSX) Q4 Earnings?

On a geographic basis, every Boston Scientific (BSX) market in fourth-quarter 2021 is expected to have registered broad-based growth compared with the dull fourth-quarter 2020 numbers.

Boston Scientific (BSX) Hit by Procedure Deferrals Amid COVID

Although Boston Scientific (BSX) reports margin expansion on a year-over-year basis, the decline in R&D expenses is concerning.

Riya Anand headshot

4 Internet of Medical Things (IoMT) Stocks to Buy for 2022

Stocks like Boston Scientific (BSX), Medtronic (MDT), DexCom (DXCM) and Syneos Health (SYNH) are evolving rapidly in the field of IoMT.

The Zacks Analyst Blog Highlights: JPMorgan, Walmart, PayPal, Equinix and Boston Scientific

The Zacks Analyst Blog Highlights: JPMorgan, Walmart, PayPal, Equinix and Boston Scientific

Mark Vickery headshot

Top Analyst Reports for JPMorgan, Walmart & PayPal

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Walmart Inc. (WMT), and PayPal Holdings, Inc. (PYPL).

Mark Vickery headshot

Top Analyst Reports for JPMorgan, Walmart & PayPal

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Walmart Inc. (WMT), and PayPal Holdings, Inc. (PYPL).

Boston Scientific (BSX) New Buyouts Aid Amid COVID Resurgence

Boston Scientific's (BSX) new acquisitions like Preventice, Farapulse and Lumenis Surgical, which closed in March, August and September of 2021, respectively, are contributing to its inorganic growth.

Here's Why You Should Retain Boston Scientific (BSX) for Now

Investors are optimistic about Boston Scientific (BSX) owing to its solid third-quarter performance and impressive value-added acquisitions.

The Zacks Analyst Blog Highlights: Alibaba, Abbott Laboratories, T-Mobile, Anheuser-Busch and Boston Scientific Corp

The Zacks Analyst Blog Highlights: Alibaba, Abbott Laboratories, T-Mobile, Anheuser-Busch and Boston Scientific Corp

Sheraz Mian headshot

Top Analyst Reports for Alibaba, Abbott & T-Mobile US

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Abbott Laboratories (ABT), and T-Mobile US, Inc. (TMUS).

QIPT vs. BSX: Which Stock Should Value Investors Buy Now?

QIPT vs. BSX: Which Stock Is the Better Value Option?

Urmimala Biswas headshot

4 Medical Products Stocks Poised to Beat This Earnings Season

Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.

Boston Scientific (BSX) Q3 Earnings Top Estimates, Margins Up

Barring CRM, Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in Q3.

Boston Scientific (BSX) Q3 Earnings Beat Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of 2.50% and -1.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Products Stock Q3 Earnings on Oct 27: TMO, EW & More

With the pandemic raging on, testing, vaccine and therapeutic makers witness huge market adoption of their COVID-related support products in Q3.

Boston Scientific (BSX) Product Launches to Drive Q3 Earnings

Within Urology/ Pelvic Health, Boston Scientific (BSX) is expected to have registered strong sales growth in Stone, Prostate Health and Pelvic Health franchises.

Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Reasons to Hold on to Boston Scientific (BSX) Stock For Now

Investors are optimistic about Boston Scientific (BSX) given its recent acquisitions and strength in the structural heart business.

Boston Scientific's (BSX) Ranger DCB Trial Outcome Favorable

Boston Scientific's (BSX) Ranger DCB two-year data demonstrates a constant, high rate of efficacy in patients with more complex lesion subtypes.

Boston Scientific (BSX) Reports Data Backing Eluvia Stent

The positive data demonstrated the superiority of Boston Scientific's (BSX) Eluvia stent compared to bare metal stents in treating patients with peripheral artery disease.

The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific Corp, Catalent, Baxter International and Hill-Rom Holdings

The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific Corp, Catalent, Baxter International and Hill-Rom Holdings

Debanjana Dey headshot

MedTech Thrives on M&A Frenzy: 3 Stocks to Focus on

MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Investors are optimistic about Medtronic (MDT) owing to new product flow and strong market share gain across the company's businesses.

NVST or BSX: Which Is the Better Value Stock Right Now?

NVST vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Strategic Buyouts Aid Amid Cost Woes

Boston Scientific (BSX) is optimistic about its recent deal to acquire Israel-based Lumenis that develops and commercializes energy-based medical solutions.